日本語

Deciding to Raise: The Readiness Checklist Before a Series B

Key Series B Facts (2026)

  • Median Series B valuation: $75-90M pre-money for B2B SaaS (Pitchbook Q1 2026 data), compressed ~30% from 2021 peak
  • ARR threshold to credibly raise: $8-15M ARR minimum; median Series B company enters raise at $12M ARR with >100% NRR
  • Close rate on Series B processes: Only ~35% of companies that formally launch a Series B close on term sheet within 90 days; 25% pull the process entirely
  • Average raise timeline: 4-6 months from first investor meeting to wire (NVCA 2025), up from 8-10 weeks in 2021
  • PMF proof, not just revenue: 78% of tier-1 Series B investors cite "repeatable, non-founder-led sales motion" as a harder bar than the ARR number itself (Bessemer 2025 LP survey)

The call comes in from a board member. A tier-1 VC partner who they know took a meeting with you three months ago reached back out. They're interested. Could you come in and pitch?

For most CEOs, this is when the Series B process starts. Not when the company is ready. When an investor is interested. The gap between those two things is where most premature Series B processes go wrong.

Three months later, you've been in 40+ investor meetings, your CFO has spent 60 hours on the data room, your head of sales has been pulled into investor diligence sessions instead of closing deals, and you've discovered mid-process that your NRR isn't where it needs to be, your sales motion is harder to explain than you thought, and your second-line management team isn't as strong as the narrative implied.

You either raise anyway at worse terms than you should have gotten, or you pull the process. Either way, you've paid a significant cost in leadership bandwidth and organizational distraction, for a process that started because you responded to investor interest rather than completing an honest readiness assessment first.

Why This Decision Is Harder Than It Looks

Series B decisions are driven by the wrong signals.

Investor interest is not the same as investor readiness. A VC taking a meeting is weak signal. It's their job to meet interesting companies. It doesn't mean you're ready to raise or that you'll close the round. NVCA (National Venture Capital Association) research on Series B dynamics consistently shows that companies which initiate fundraising processes before reaching metrics thresholds receive materially worse valuations and terms than those who raise from a position of prepared strength.

Competitor fundraising is not a reason to raise. The competitor raised money because they convinced investors of their story. It says nothing about whether your company should accelerate its capital consumption right now.

Board anxiety is not a readiness signal. Boards sometimes push for a raise because they're worried about runway, worried about falling behind, or responding to LP pressure. Their anxiety is real data about board dynamics, not about your company's readiness.

The real question (the one most CEOs skip) is not "can we raise?" Most B2B SaaS companies with reasonable metrics can raise. The question is: should we raise now, and will we be able to deploy this capital into something that actually works? The answer requires applying the same discipline as the cash-vs-growth quarterly tradeoff: evidence-backed payback confidence and an honest read of the market clock.

That question requires a readiness assessment, not an investor pipeline.

The Series B PMF-Proof Metrics

Top-tier Series B investors are not buying your ARR — they are buying evidence that a dollar of capital reliably produces a predictable dollar of recurring revenue without the founder in the room. The Series B PMF-Proof Metrics are the four numbers that demonstrate this: 12-month NRR above 110% (enterprise) or 100% (mid-market), CAC payback under 18 months with segment-level cohort data, win rate stability across at least three non-founder reps, and gross margin trending above 70%. When all four clear the bar simultaneously, the round prices on multiple expansion; when any one is soft, the round prices on discount — regardless of topline ARR.

The 5-Category Readiness Checklist

Category 1: Metrics Maturity

Series B investors are looking for proof of a repeatable business model. That proof lives in your metrics, but it has to be clean, consistent, and defensible under scrutiny.

The baseline requirements:

  • 12+ months of clean ARR data: Month-by-month ARR, with clear methodology for what counts (no bookings confusion, no MRR/ARR conflation)
  • Net Revenue Retention: Do you have 12 months of NRR data? Is it above 110% for enterprise, above 100% for mid-market? If NRR is below 100%, that's a pre-raise fix, not a Series B storyline. KeyBanc's annual SaaS survey (via Bessemer Venture Partners' State of the Cloud) tracks NRR benchmarks by segment. Median enterprise SaaS at Series B stage runs 115-125% NRR.
  • CAC and payback period: Do you know your blended CAC? Your payback period by segment? Can you explain how these have trended and why?
  • Gross margin: Is it consistent and trending toward software-level margins if you have services revenue mixed in?

Self-assessment: Can you hand your CFO a 10-question financial diligence list from a Series B investor and be confident that all 10 answers are clean, consistent, and defensible? If not, that's a signal you need 60-90 more days on metrics cleanup before you start the process.

Score this 1-5: 1 = metrics are messy or incomplete, 5 = all metrics are clean, auditable, and tell a consistent story.

Category 2: Go-to-Market Repeatability

One of the most common Series B failure modes is a company that has grown but can't explain why. Revenue is up, but the growth was a combination of founder relationships, a few large inbound deals, and a partnership that may not be repeatable.

Investors are looking for a documented, replicable sales motion: you understand who you sell to, how you find them, how you sell to them, and what the win rate and sales cycle look like across multiple reps.

The test questions:

  • Can you describe your Ideal Customer Profile in one sentence with specifics? (Not "mid-market companies" but "150-500 employee B2B software companies in manufacturing and professional services with a specific tech stack")
  • Have you had at least three sales reps (not the founders) sell successfully through the full sales cycle?
  • Do you have a win rate by segment, by competitor, by deal size?
  • Can you explain what causes deals to stall and what the recovery rate is?

If the answers are vague or dependent on founder involvement, your sales motion isn't repeatable enough for a Series B. The fix is 6-12 months of documented, founder-independent sales execution.

Score this 1-5: 1 = sales is largely founder-dependent or relationship-driven, 5 = documented, multi-rep, segment-specific sales motion with trackable win rates.

Category 3: Leadership Depth

Series B capital typically funds an 18-24 month plan to significantly scale the team. The question investors are asking: do you have the leadership team to execute that plan without the CEO in every room? This is also the moment when hiring a Chief of Staff goes from optional to necessary. The coordination overhead of a scaling organization while running a fundraise is genuinely unmanageable without one.

The specific tests:

  • Do you have a VP or above in Sales, Marketing, and Product who is founder-independent (meaning the function would continue to work if the CEO stopped attending their weekly team meetings)?
  • Do you have leaders who have operated at the next scale before? (A VP of Sales who has built a team from 5 to 25 before is significantly more credible than one who has only operated at 3-7 reps)
  • Do you have second-line managers? (At Series B, investors are scaling into the management layer below the VPs. Those managers need to exist or be in the near-term hire plan)

Leadership gaps are not disqualifying, but they need to be acknowledged honestly and reflected in the use-of-funds. If you're planning to hire three C-suite leaders with Series B capital, that's a different use-of-funds story than "we have a full team and are scaling proven motions."

Score this 1-5: 1 = leadership team is thin or primarily founder-dependent, 5 = full VP team with demonstrated scale experience and emerging second-line management.

Category 4: Capital Deployment Clarity

This is the question most CEOs answer too vaguely: what will you do with the $15-25M?

The test is not whether you can produce a use-of-funds spreadsheet. It's whether the use of funds reflects a clear theory of growth, and whether you can defend each major investment with specific assumptions and payback logic.

The questions you should be able to answer:

  • How many sales reps are you planning to hire, and what does the ramp model look like?
  • What is the expected CAC and payback for the segment you're expanding into?
  • What is the product investment, and what customer outcome does it unlock?
  • What is the go-to-market investment, and what's the pipeline coverage model?

If the use-of-funds looks like "hire across all functions" without specific assumptions about what each investment returns, you don't have a deployment plan. You have a growth aspiration. Investors can tell the difference.

Score this 1-5: 1 = use of funds is general and aspiration-driven, 5 = specific deployment plan with assumptions, model, and payback logic for each major investment.

Category 5: Market Narrative

The final category is whether you can tell a credible story about market size and why you win.

The test: can a Series B investor make a defensible argument to their LP advisory board that this is a large market with durable tailwinds and that your company has a structurally advantaged position in it?

Common failure modes:

  • The market size calculation is obviously inflated (total addressable market that includes companies you can't actually sell to)
  • The "why we win" is vague ("we have better technology" or "we're more focused on the customer")
  • The moat isn't real (network effects, switching costs, data advantage, distribution that you claim but can't demonstrate)

The market narrative doesn't need to be a large public market. Some excellent Series B companies operate in narrow markets with compelling structural dynamics. But the narrative needs to be credible under scrutiny, not borrowed from a market research report.

Score this 1-5: 1 = market narrative is vague or hard to defend, 5 = clear market thesis with specific evidence for size, tailwinds, and your structural position.

Interpreting the Scores

Total 20-25: Strong readiness. Start the process.

Total 15-19: Conditional readiness. Identify the specific gaps in categories scoring below 4 and set a 60-90 day plan to address them. Then reassess.

Total below 15: Not ready. The process will be painful, the terms will be worse than they should be, and you'll be distracted from the business during a period when the business needs your attention. Wait.

The most important use of this assessment is identifying which specific categories are weak. A company that scores 5/5/5/5/2 on the five categories has a market narrative problem. A company that scores 2/4/5/5/5 has a metrics maturity problem. The remediation is different. The timeline is different. But in both cases, 60-90 days of focused work on the weak category will materially improve the outcome.

Two Illustrations

Fixing NRR Before Going to Market

A 160-person SaaS company had been planning a Series B for 18 months. Their ARR was strong, their sales motion was documented, and their leadership team was solid. But their NRR was 97%, just below the 100% threshold that enterprise SaaS investors expect.

The CEO took the readiness checklist seriously. Metrics maturity scored 3/5 because of the NRR problem. Rather than starting the process with a weak NRR story ("we're working on improving it"), the CEO made a call: delay the raise by 8 months and fix the retention problem first.

In those 8 months, the company identified the cohort driving the churn (primarily small-enterprise accounts below $25K ACV), restructured the CS motion for that cohort, and started seeing NRR improve. By the time they went to market, NRR was 106%. They raised at a significantly better multiple than they would have with 97% NRR, and the process was cleaner because the story was clean.

Raising Before the Sales Motion Was Proven

A 120-person company started their Series B process with a board member's encouragement, a strong-looking ARR number, and an investor who was interested. What they hadn't done was the readiness assessment.

Their go-to-market repeatability score would have been 2/5. Three of their largest accounts had come through founder relationships, and they had only two quota-carrying reps who had completed a full sales cycle without founder involvement. Unproven sales repeatability is a structural gap that shows up immediately in investor due diligence, and the first 90 days of a sales leader's tenure is often the window where that documentation gets built or reveals it doesn't exist.

They raised the round but spent the first 12 months trying to prove a sales motion that didn't exist yet. The 8 AE hires funded by the Series B were operating without a documented playbook. Win rates were inconsistent. CAC was 40% higher than the model assumed. By month 18, they were back at the board with a revised plan and a request to reforecast the model.

The 90-Day Pre-Raise Timeline

If the readiness assessment shows you're at 20+ and ready to proceed:

  • Days 1-30: Internal preparation. Finalize metrics cleanup. Complete the use-of-funds model with assumptions. Prepare the narrative deck. Begin populating the data room.
  • Days 31-60: Soft outreach. Identify the 15-20 investors you want to meet first. Through board members and advisors, arrange first conversations without formally launching the process.
  • Days 61-90: Formal process. Launch the formal raise, set a timeline, and run a competitive process if possible. Never raise without competition. Price is set by alternatives.

The data room should be ready before the first investor meeting. Not after you've decided to proceed. Before. Investors who are serious ask for the data room within 2 weeks of the first meeting. If you're not ready when they ask, you lose momentum.

How Rework Work Ops Fits Pre-Raise Metrics Tracking

The readiness gap that kills most Series B processes isn't the metrics themselves — it's the 60-90 days the CFO spends reconstructing them from ten disconnected tools two weeks before the data room goes live. By that point, anything inconsistent becomes a diligence question rather than a defensible number.

Rework Work Ops (from $6/user/mo) gives the CFO and CEO one place to track the board-facing metrics on a rolling basis — NRR cohorts, CAC payback by segment, pipeline coverage, hiring plan actuals against the use-of-funds model, and second-line manager hiring velocity. Because it connects to the CRM side (Rework CRM/Sales Ops from $12/user/mo) and the hiring workflows in the same workspace, the numbers you show a board in month 14 are the same numbers the data room surfaces in month 18 — no reconciliation, no "which version is right."

Teams running the full Rework stack typically compress the pre-raise metrics-cleanup sprint from 90 days to 30, because the cohort data and win-rate-by-rep views already exist. It's not a shortcut through readiness — it's faster evidence that you already were ready.

Raising Money Is Not the Achievement

The goal isn't the close. The goal is deploying the capital into something that works, and coming out the other side of the 18-24 month deployment period with significantly better unit economics, more durable growth, and a stronger position than when you started. Bain & Company's research on growth equity outcomes shows that companies raising growth rounds with clear deployment plans and proven unit economics outperform those raising on momentum alone by a wide margin over 3-year holding periods.

That only happens when you raise from a position of genuine readiness. When the metrics are clean, the motion is proven, the team can execute, the deployment plan is specific, and the narrative is credible.

Start with the readiness assessment, not the investor meeting.

Frequently Asked Questions

Frequently Asked Questions

What ARR do I need to raise a Series B in 2026?

The credible floor is $8M ARR, the median is $12M, and $15M+ is where you gain real leverage in terms. But ARR alone is not sufficient — tier-1 investors routinely pass on $20M ARR companies with weak NRR or founder-dependent sales, and they take $9M ARR companies with 125% NRR and proven multi-rep motion.

What metrics matter most at Series B?

In order of weight: Net Revenue Retention (110%+ enterprise, 100%+ mid-market), CAC payback period (under 18 months), gross margin (70%+), and win rate consistency across non-founder reps. Growth rate matters but is evaluated in context of these four — 80% YoY growth with 90% NRR is worse than 45% growth with 125% NRR.

How long should a Series B raise take?

From first meeting to wire, budget 4-6 months in the 2026 environment (up from 8-10 weeks in 2021). The formal process window — term sheet to close — is typically 45-60 days. If a CEO is promising the board a 60-day total process, they're either raising from existing investors or setting the board up for a miss.

When is a company NOT ready for Series B?

Three disqualifying signals: NRR below 100%, fewer than three non-founder reps who have closed a full sales cycle, or use-of-funds framed as "hire across functions" without CAC/payback assumptions per hire. Any one of these should delay the raise by 60-180 days. Raising with these gaps results in worse terms and a round that funds discovery work instead of scaling work.

What's the biggest Series B pitch mistake?

Leading with ARR growth rate instead of unit economics. Investors have seen the 2021-2022 cohort of high-growth companies with broken unit economics hit the wall in 2024-2025. Narrative that opens with "we tripled ARR last year" without immediately establishing payback, NRR, and margin triggers skepticism, not excitement. Lead with the durable metrics; ARR growth is the output.

Should I raise Series B or bootstrap longer?

Raise if (a) you have a specific deployment plan with defensible payback assumptions, (b) the market window rewards speed-to-scale in your category, and (c) you can tolerate the dilution and board expansion. Bootstrap (or extend with a bridge/insider round) if your deployment plan is still speculative or if 12 more months of organic growth would let you raise at a materially better valuation. The worst outcome is raising on momentum, spending the round on discovery, and returning to market diluted with unchanged unit economics.

Do I need a banker for a Series B?

Usually no. Bankers are standard at Series C and above. At Series B, a well-connected board and a prepared CEO outperform a banker in most cases — investors prefer direct CEO contact at this stage, and banker fees (typically 2-4% of the raise) are meaningful. Exceptions: CEOs with no VC network, specialized verticals where a banker has unique relationships, or situations where the CEO cannot afford the bandwidth cost of running the process directly.

Is it okay to raise from existing investors only (insider round)?

An insider-led round is fine when the metrics support a valuation step-up and the existing investors can lead at price. It becomes a warning sign when outside investors pass and existing investors step in at a flat or down round to keep the company alive. Boards and future investors can tell the difference, and the latter materially complicates your next raise.

Learn More